A New Device for Early Detection of Breast Disease: Stakeholders Perspective Analysis in Brazil/LATAM/LMIC

Moderator

ELIO TANAKA, MD, TNK MEDICAL AUDIT INSTITUTION, CURITIBA, Brazil

Speakers

Jorge Salazar; Claudio Tafla; EDUARDO Ramos; FABIO FRANCO; Francisco Prota, Unimed Campinas, Campinas, Brazil; Ana Paula Rodrigues, .; Débora Fernanda Guisso, MD

OBJECTIVES: A device for breast disease aims to deliver a safe, effective, non-invasive, easy-to-use technology to support physical breast examination.Update providing an approach to breast healthcare, potentially saving lives . Our aim is to describe the incorporating process for a new device for early detection of breast disease and the consequences for the treatment of breast diseases in Brazil. Since the researchers has given us a chance to contribute to the health care and had a tremendous opportunity to help many women, regardless of their socioeconomic status, with the solution for early breast disease detection , we study this opportunity .
METHODS: RWD & RWE review literature of thermal screening device consisting of two disposable pads with photochromic sensors for Breast ( Celbrea ) .
RESULTS: This approach to breast care allows physicians to evaluate patients’ breast health with a painless procedure and give results and reassurance on the spot. The clinical data showed that is safe, effective, and reliable. Besides, provides a complementary modality to mammography and other established procedures and serves as a valuable additional information in the process of breast disease detection. Women who will benefit the most from this are women with inconclusive imaging results , dense breasts and young women ( less than 40 years ) . 87 % of specificity , 99 % of NPV (negative predictive value) , and 86 % of sensitivity . Given its high NPV, it can support physicians with a more comprehensive clinical decision on next steps. Plus, consistent sensitivity level across tumor size and proven effectiveness across all age groups.
CONCLUSIONS: Our stakeholders perspectives analysis is that who not incorporate this innovation , early , are losing chances of increase sustenability in their health care system by analysis of the waste pharmacoeconomic comparisons tools .

Conference/Value in Health Info

2025-05, ISPOR 2025, Montréal, Quebec, CA

Value in Health, Volume 28, Issue S1

Code

EE27

Topic

Economic Evaluation

Topic Subcategory

Budget Impact Analysis, Thresholds & Opportunity Cost, Trial-Based Economic Evaluation, Value of Information

Disease

SDC: Oncology

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×